Zdrowie i gospodarka · 10/03/2005

FDA Proposes Reclassification of Automated Blood Cell Separator Device

The US Food and Drug Administration (FDA) is proposing to reclassify an automated blood cell separator device from Class III to Class II, a move aimed at improving the safety and effectiveness of the device, which is used to collect blood and blood components, and is intended for routine use.